Cargando…
Clinical Results in Medullary Thyroid Carcinoma Suggest High Potential of Pretargeted Immuno-PET for Tumor Imaging and Theranostic Approaches
Monoclonal antibody (mAb)-based therapies have experienced considerable growth in cancer management. When labeled with radionuclides, mAbs also represent promising probes for imaging or theranostic approaches. Initially, mAbs have been radiolabeled with single-photon emitters, such as (131)I, (99m)T...
Autores principales: | Bodet-Milin, Caroline, Bailly, Clément, Touchefeu, Yann, Frampas, Eric, Bourgeois, Mickael, Rauscher, Aurore, Lacoeuille, Franck, Drui, Delphine, Arlicot, Nicolas, Goldenberg, David M., Faivre-Chauvet, Alain, Barbet, Jacques, Rousseau, Caroline, Kraeber-Bodéré, Françoise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558173/ https://www.ncbi.nlm.nih.gov/pubmed/31214593 http://dx.doi.org/10.3389/fmed.2019.00124 |
Ejemplares similares
-
Pretargeting for imaging and therapy in oncological nuclear medicine
por: Bailly, Clément, et al.
Publicado: (2017) -
A pretargeting system for tumor PET imaging and radioimmunotherapy
por: Kraeber-Bodéré, Françoise, et al.
Publicado: (2015) -
Sensitivity of pretargeted immunoPET using (68)Ga-peptide to detect colonic carcinoma liver metastases in a murine xenograft model: Comparison with (18)FDG PET-CT
por: Foubert, Fanny, et al.
Publicado: (2018) -
Improvement of Radioimmunotherapy Using Pretargeting
por: Frampas, Eric, et al.
Publicado: (2013) -
Immuno-PET for Clinical Theranostic Approaches
por: Bailly, Clément, et al.
Publicado: (2016)